(Q33569526)

28 July 2017

1 reference

title

Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections (English)

1 reference

28 July 2017

0 references

Davis R

1

1 reference

28 July 2017

Balfour JA

series ordinal

2

1 reference

28 July 2017

publication date

1 September 1995

1 reference

28 July 2017

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

253-269

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199508030-00008

28 July 2017

exact match

0 references

cites work

Comparison of terbinafine and clotrimazole in treating tinea pedis

1 reference

12 December 2020

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group

1 reference

12 December 2020

The mechanism of action of terbinafine

1 reference

12 December 2020

Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis

1 reference

12 December 2020

Recording of possible side effects in the Bureau for Side Effects of Drugs and research activities in 1992

1 reference

12 December 2020

Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections

1 reference

12 December 2020

The Activity of Ketoconazole in the Treatment of Onychomycosis

1 reference

12 December 2020

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

12 December 2020

Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective

1 reference

12 December 2020

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group

1 reference

12 December 2020

Taste disorders and terbinafine

1 reference

12 December 2020

Oral Therapy with Ketoconazole for Dermatophyte Infections Unresponsive to Griseofulvin

1 reference

12 December 2020

Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study

1 reference

12 December 2020

A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis

1 reference

12 December 2020

Onychomycosis is more than a cosmetic problem

1 reference

12 December 2020

[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]

1 reference

12 December 2020

Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin

1 reference

12 December 2020

A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis

1 reference

12 December 2020

Mechanisms of action of the antimycotic imidazoles

1 reference

12 December 2020

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

12 December 2020

An evaluation of itraconazole in the management of onychomycosis

1 reference

12 December 2020

Ketoconazole and hepatic reactions

1 reference

12 December 2020

A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.

1 reference

12 December 2020

Terbinafine: An oral and topical antifungal agent

1 reference

12 December 2020

Mycology of nail disorders

1 reference

12 December 2020

Oral therapeutic agents in fungal nail disease

1 reference

12 December 2020

Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks

1 reference

12 December 2020

Patient noncompliance in dermatomycosis. Results of a survey among dermatologists and general practitioners and patients

1 reference

12 December 2020

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

12 December 2020

Antifungal drugs in dermatology.

1 reference

12 December 2020

Special features of the clinical use of oral terbinafine in the treatment of fungal diseases

1 reference

12 December 2020

Treatment of onychomycosis with terbinafine

1 reference

12 December 2020

Imidazoles and triazoles in antifungal therapy.

1 reference

12 December 2020

Toxic hepatis during ketoconazole treatment.

1 reference

12 December 2020

Allylamine antifungal drugs

1 reference

12 December 2020

Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase

1 reference

12 December 2020

Hepatitis associated with terbinafine treatment

1 reference

12 December 2020

A randomized treatment duration-finding study of terbinafine in onychomycosis

1 reference

12 December 2020

Short term treatment of dermatophyte onychomycosis with terbinafine

1 reference

12 December 2020

Efficacy and safety of itraconazole in the long-term treatment of onychomycosis

1 reference

12 December 2020

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

1 reference

12 December 2020

Skin manifestations in AIDS patients

1 reference

12 December 2020

Azoles, a48 llylamines and drug metabolism

1 reference

12 December 2020

Clinical singgnificance of interactions with antifungal agents

1 reference

12 December 2020

A cost analysis of topical drug regimens for dermatophyte infections

1 reference

12 December 2020

Management of onychomycosis with oral terbinafine

1 reference

12 December 2020

Loss of taste and terbinafine

1 reference

12 December 2020

Azole antifungal agents: emphasis on new triazoles

1 reference

12 December 2020

Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials

1 reference

12 December 2020

Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients

1 reference

12 December 2020

Itraconazole in onychomycosis. Open and double-blind studies

1 reference

12 December 2020

Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses

1 reference

12 December 2020

Therapy of Superficial Fungal Infection

1 reference

12 December 2020

Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey

1 reference

12 December 2020

Pharmacoeconomic analysis of topical treatments for tinea infections

1 reference

12 December 2020

Pharmacokinetics of terbinafine in the nail

1 reference

12 December 2020

Quality of life of persons with onychomycosis.

1 reference

12 December 2020

1 reference

12 December 2020

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 reference

12 December 2020

Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole

1 reference

12 December 2020

Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi

1 reference

12 December 2020

Global overview of Lamisil.

1 reference

12 December 2020

Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis

1 reference

12 December 2020

Treatment of dermatomycoses and onychomycoses--state of the art

1 reference

12 December 2020

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases

1 reference

12 December 2020

Diagnosis and treatment of tinea pedis. A review and update

1 reference

12 December 2020

10.2165/00019053-199508030-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1043252955

0 references

1 reference